Clearstead Advisors’s Eikon Therapeutics EIKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$81 Buy
+10
New +$101 ﹤0.01% 3286

Other funds holding EIKN

Clearstead Advisors's EIKN Position: Q3 2026 in Review

Clearstead Advisors opened a new position in Eikon Therapeutics (EIKN) in Q3 2026: 10 shares worth $81. The stake represents ﹤0.01% of the portfolio and ranks #3286 among its holdings.

98 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

  • Clearstead Advisors held 10 shares of Eikon Therapeutics worth $81 as of Q3 2026.
  • Eikon Therapeutics was a new Clearstead Advisors position in Q3 2026.
  • Eikon Therapeutics made up ﹤0.01% of Clearstead Advisors's portfolio in Q3 2026, its #3286 holding.
  • 98 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on Clearstead Advisors's 13F filing for Q3 2026, filed 6 Nov 2026.